hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cellsig.2021.110106
PubMed Identifier: 34363951
Publication URI: http://europepmc.org/abstract/MED/34363951
Type: Journal Article/Review
Volume: 87
Parent Publication: Cellular signalling
ISSN: 0898-6568